Pre-hospital treatment of sepsis: reduction in mortality in severe sepsis.

Pre-hospital treatment of sepsis: reduction in mortality in severe sepsis. - pre-hospital treatment sepsis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38203

Enrollment

2200

Registered

2012-10-05

Start date

2012-11-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

The prehospital treatment group will receive 1,2 gr augmentin iv. within 30 minutes. The control group will receive no antibiotics. Before giving the augmentin, blood cultures will be taken.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) In the history signs of an infection. 2) Two of the following criteria: - Respitory Rate of > 20/min - Heart rate of > 90/min - A body temperature of > 38 degrees celsius or

Exclusion criteria

Exclusion criteria: 1) Allergy for beta-lactam. 2) Age

Design outcomes

Primary

Measure	Time frame
The reduction of mortality in patients with severe sepsis.	—

Secondary

Measure	Time frame
Prehospital treatment related to the organism, co-morbidity, co-medications, gender, age. Comparison of the intervention group and control group with APACHE/NICE score.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)